4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-036517
Director bought 5,000 shares at an average $58.04 ($290,212)
From the SEC's structured data for this filing
Trades in this filing
WHITFIELD ROY A · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-06-05 | Purchase : show line 1 in the form | +1,600 | $55.22 | $88,352 | 173,600 | D |
| 2018-06-06 | Purchase : show line 2 in the form | +2,000 | $59.07 | $118,140 | 175,600 | D |
| 2018-06-06 | Purchase : show line 3 in the form | +1,400 | $59.80 | $83,720 | 177,000 | D |
| Open-market purchases · 5,000 sh · avg $58.04 · $290,212 | ||||||
Loading xslF345X03/doc4.xml…